TOP2A and non-small cell lung carcinoma: A multicenter next generation sequencing and gene expression study of ~17,000 unmatched primary tumors from non-small cell lung cancer (NSCLC), breast cancer and melanoma demonstrated higher TOP2A expression in brain metastases (21).